INTRODUCTION
The vitamin K-dependent carboxylation of glutamate residues (Suttie, 1984 ) is a two-step reaction: the C-4-H-4 bond is cleaved first and the intermediate thus generated reacts with a CO2 moiety, leading to 4-carboxyglutamate.
The hydrogen-exchange studies by McTigue & Suttie (1983) , Anton & Friedman (1983) and Ducrocq et al. (1986) established (i) that the reaction is-not concerted (the hydrogen exchange occurs in the absence ofcarboxylation), (ii) that the hydrogen exchange is vitamin Kdependent, (iii) that the hydrogen exchange is faster than the CO2 fixation and (iv) that the stereospecificity of the hydrogen exchange is the same as the stereospecificity observed during carboxylation.
So far, two mechanisms have been considered for the hydrogen-abstraction step: either a radical-mediated mechanism (pathway a) or a carbanion-mediated mech- The exchange experiments, although they do not strictly rule out the formation of a radical, were interpreted as favouring the carbanion-mediated mechanism. On the other hand, the hypothesis of a radical intermediate is supported by early work by Girardot et al. (1976) , who described the inhibition of the carboxylation by spin-trapping reagents. However, no adduct has been unambiguously characterized by e.s.r. We decided to test the carbanion hypothesis by using a fl-elimination strategy similar to that developed by Abeles and Stubbe, who investigated the non-concerted nature of propionyl-CoA carboxylase mechanism by using ,-fluoropropionyl-CoA (Stubbe & Abeles, 1977; Stubbe et al., 1980) . During carboxylation, formation of a carbanion ,l to the fluorine atom could induce a ,-elimination and yield a dehydroglutamyl moiety (Scheme 2). Alternatively, as suggested by our study on model fluorine-containing radicals, a radical-mediated mechanism would yield the carboxylation product rather than the elimination of a fluorine radical (Vidal-Cros et al., 1 989a).
In the present paper we report the synthesis of BocXaa-Glu-Val tripeptides, where Xaa is a 3-substituted glutamic acid, and their behaviour upon interaction with the vitamin K-dependent carboxylating system.
EXPERIMENTAL Chemicals
Hydroxybenzotriazole, dicyclohexylcarbodi-imide and N-hydroxysuccinimide were from Fluka Co. Di-t-butyl pyrocarbonate, NADH, NAD+, pyridoxal 5'-phosphate, dithiothreitol, Triton X-100, sucrose, leucine aminopeptidase and acylase I were from Sigma Chemical Co., and all amino acids and derivatives were from Bachem.
All other chemicals were of the highest purity available. The (2R,3R)-(threo)-and (2R,3S)-(erythro)-3-fluoroglutamic acids were synthesized as described by VidalCros et al. (1989b) (Guchhait et al., 1974 
were synthesized by the liquid-phase methodology with t-butyloxycarbonyl group for amino-group protection and benzyl ester for carboxy-group protection. Coupling was performed through the N-hydroxysuccinimic ester. After purification by column chromatography on silica gel, the protected tripeptides were hydrogenolysed with 10 0 Pd on charcoal.
Since 3-fluoroglutamic acid is degraded during hydrolysis with 1 M-HCl (Vidal-Cros et al., 1985a) , no amino acid analysis could be performed. The purity of peptides was checked by h.p.l.c. and 200 MHz 'H-n.m.r. Liver microsomal fractions were prepared from warfarin-treated rats (13.4 mM, 10 mg/kg) as previously described Decottignies-Le Marechal et al., 1980) . The incubation mixture (final pH 7.58) contained 50 mM-KH2PO4, 0.6 M-KCl, 0.25 Msucrose, 1.33 mM-pyridoxal 5'-phosphate, 2.22 mM-NADH, 3.9 ,#M-NAD', 0.39 mM-dithiothreitol, 0.22 mMvitamin K1 hydroquinone, 1.50% (v/v) Triton X-100, 7-9 mg of microsomal protein/ml and 1-3 mM-peptide. After preincubation (5 min at 20°C), the reaction was initiated by addition ofNaH14CO3 (0.32 mM) and stopped after 30 min by addition of trichloroacetic acid [100% (w/v) 
Boc-Glu(A3 4)-Glu-Val (1 mM) was incubated at 22°C in the incubation mixture described above but containing heat-denatured microsomal fraction and non-labelled NaHCO3. The reaction was monitored over a 5 h period on samples previously precipitated with ethanol (5000, v/v), and centrifuged. H.p.l.c. analysis was performed on a ,uBondapak C18 column, eluted with 0.25 mMtriethylammonium phosphate, pH 3, containing 220 (v/v) acetonitrile at a rate of 1 ml/min and monitored at 210 nm.
Incubation of the Boc-Glu(3F)-Glu-13HJVal tripeptides
The assay was run on Boc-Glu(3F)-Glu-[3H]Val (3 mM; 0.28 mCi/mmol) in a 2 ml total volume in the standard conditions, except that non-radioactive NaHCO3 (0.32 mM) was included. After incubation at 20°C for 2 h, proteins were precipitated by ethanol (2 ml) and centrifuged at 1000 g for 15 min. The whole supernatant was then incubated at 20°C for 3 h and concentrated to dryness. A sample of the crude mixture was analysed by h.p.l.c. on a Merck Lichrospher 100 RP8e (5 ltm particle size) column eluted at 1 ml/min with 0.25 M-triethylammonium phosphate, pH 3, containing 18 00 (v/v) acetonitrile. Fractions (1 ml) were collected and radioactivity was determined. A blank experiment where vitamin K was omitted was run in the same conditions.
Purification of the product derived from incubation of erythro-Boc-Glu(3F)-Glu-13HIVal
The crude product was purified by h.p.l.c. on a Merck Lichrosorb RP-18 (1 ,um particle size) column eluted at 3 ml/min with 0.25 mM-triethylammonium phosphate, pH 3, containing 180 (v/v) acetonitrile. Fractions (3 ml) were collected. The dehydropeptide-like fractions, detected by u.v. light at 210 nm, were pooled, concentrated under reduced pressure and freeze-dried. The salts were removed by purification of the recovered material on a C18 Sep-Pak cartridge. After being washed with 70 ml of water, the product was eluted with 3 ml of methanol. The radiochemical purity of the product was checked again by h.p.l.c. Identification of the product derived from incubation of erythro-Boc-Glu(3F)-Glu-13H1Vat
The above purified product, diluted with non-labelled Boc-Glu(A2' 3)-Glu-Val (0.4 umol), was hydrogenated with 100 Pd on charcoal in 0.75 ml of methanol. After vigorous stirring for 3 h, the catalyst was filtered off and washed with methanol, and the product was analysed by h.p.l.c. on a Merck Lichrospher 100 RP-8e (5 ,um particle size) column eluted at 1 ml/min with 0.25 Mtriethylammonium phosphate, pH 3, containing 12.80 (v/v) acetonitrile. Fractions (either 1 ml or 0.2 ml) were collected and radioactivity was determined on 0.2 ml samples. Tritium release assay Buffers and solutions were prepared with freshly boiled water in order to lower the bicarbonate concentration down to 0.5-1 mm. An incubation was run on 6.75 #tCi of Boc-(2S)-[2,3-3H]Glu-Glu-Val (1 mM; specific radioactivity 13.5 mCi/mmol) as described for a standard assay. After incubation at 20°C for 5 h, the proteins were precipitated by addition of trichloroacetic acid [100% (w/v) 
RESULTS

Carboxylation of fluoropeptides
Since the carboxylation of Phe-Leu-Glu-Glu-Val or Boc-Glu-Glu-Val occurs almost exclusively at the first glutamate residue (Decottignies-Le , the 3-substituted glutamates were introduced at that position. To facilitate the detection and the purification of the products formed upon reaction of the fluorinated substrates, radioactive peptides labelled with [3H]valine were prepared. The tripeptides were synthesized by the liquid-phase method, with t-butyloxycarbonyl group for amino-group protection and benzyl ester for carboxy-group protection, and tested for carboxylation. Results are given in Table 1 .
As already observed, the tripeptide Boc-Glu-Glu-Val, although being one of the best of the synthetic peptides commonly used to study vitamin K-dependent carboxylation (Rich et al., 1980) , remained a poor substrate for the enzyme (0.1 00 reaction at a peptide concentration of 1 mM with 30 min incubation time). However, the "CO2 incorporations with this substrate were significant with respect to the very low value of the blanks (see Table 1 ).
On the other hand the "CO2 incorporation into both fluorinated peptides was not significantly different from the blank and they could not thus be considered as being substrates of the carboxylase. I Fluorinated analogues bear some resemblance to their hydroxylated analogues (Barnett, 1972; Briley et al., 1975 material, a value that was larger than the carboxylation yield of Boc-Glu-Glu-Val, which is in the 0.3-0.4 % range under those conditions. This was consistent with the conclusion derived from exchange experiments (see above) that the slower step of the reaction is the addition of CO2 to the intermediate. To reinforce the identification of the product as the dehydropeptide, we ran a hydrogenation catalysed by Pd on charcoal. Preliminary experiments on the dehydropeptide, obtained either by isomerization of synthetic (Fig. 2) . The amounts of radioactive materials 
Glu(3F)-Glu-13HIVal
The carboxylation product of Boc-Glu(3F)-Glu-[3H]Val, purified on a Merck Lichrosorb RP-18 (7 ,um particle size) column and on a C18 Sep-Pak cartridge, was diluted with 0.4 Izmol of synthetic Boc-Glu(A2'3)-Glu-Val and hydrogenated on Pd on charcoal for 3 h in methanol. The crude product was analysed by h.p.l.c. on a Merck Lichrospher 100 RP-8e (5 ,um particle size) column. Eluting buffer was 0.25 mM-triethylammonium phosphate, pH 3, containing 12.8 % (v/v) acetonitrile, at a rate of 1 ml/min.
Monitoring of the eluate was at 210 nm ( ). Fractions (1 ml or 0.2 ml) were collected and the radioactivity was determined (. , blank; ----, assay). The arrows indicate the retention times of the standard peptides:
Vol. 266 were almost identical in both peaks, whereas the u.v. monitoring indicated an excess of the DLL-isomer over the LLL-isomer, as observed previously. This suggested that the peak corresponding to the LLL-isomer was contaminated by a radioactive impurity. A peak eluted at the retention time of the DLL-isomer was present in the blank in even higher amount than in the assay (presumably because the fractions containing eventually the dehydro compound were collected blindly to avoid loss of product) whereas nothing was eluted at the retention time of the DLL-isomer. This established (i) that no dehydropeptide was formed in the blank, and (ii) that, even though no unambiguous conclusion can be drawn from the peak eluted at the retention time of the LLL-isomer, the existence of a radioactive peak at the retention time of the DLL-isomer in the assay proves that dehydropeptide was present after incubation with the carboxylase. 
DISCUSSION
I I / N The energy required for the homolytic breaking of the C-F bond is very high (Patai, 1973) . Previous studies of a-fluoro-containing radicals suggested that the first possibility (eqn. 1) was very unlikely (Barton et al., 1966; Herdewijn et al., 1987) . We also checked (VidalCros et al., 1989a) that no elimination was occurring during the homolytic decarboxylation of the 3-fluoroglutamates according to Barton et al. (1983) . Thus the fastest reaction undergone by an a-fluoro radical is the trapping of an H' radical rather than F' radical elimination or dimerization. If a radical intermediate were involved in the carboxylation, it would probably exhibit the same reactivity and react with another radical (H' or CO2-) rather than eliminate the F' radical. Fanion elimination from a carbanion intermediate (eqn. 2), already used in many studies such as mechanismbased enzyme inhibition (Walsh, 1982; Rando, 1984) , seemed to be the most attractive of those simple mechanisms that could account for the dehydropeptide formation. [Stubbe and colleagues (Harris et al., 1987) suggested the existence of a radical cation and the HF elimination to account for the inactivation of ribonucleotide reductase by 2'-deoxy-2'-fluororibonucleotide. However, in this case the radical cation was stabilized by an adjacent donor hydroxy group.]
The dehydropeptide could also be formed by the decarboxylation of Boc-Gla(3F)-Glu-Val (Scheme 3). The fact that no 4CO2 was incorporated in the carboxylation assay excluded, a priori, a non-stereospecific decarboxylation (1"CO2 would have been present in the dehydropeptide). It would have required an efficient (concerted?) decarboxylation-fluoride elimination at the active site. This would have implied that the extent of carboxylation of Boc-Glu(3eF)-Glu-Val (1 00 in that hypothesis) exceeded that of Boc-Glu-Glu-Val (0.3-0.4 %). This makes that possibility very unlikely, since the CO2 incorporation is the slow step of the overall reaction (Ducrocq et al., 1986) . (Furthermore, malonic protons being very acidic and the presence of fluorine reinforcing this acidity, proton abstraction should be favoured over decarboxylation and should yield a 11C-labelled product in the carboxylation experiments.) The 2,3-dehydropeptide could have been produced directly by elimination on a carbanion non-specifically generated at the 2-position. However, the stability of the fluorinated peptide under the incubation conditions and the strict dependence of the elimination on the presence of vitamin K make this possibility improbable also. (We checked that no exchange ofthe 2-hydrogen of Boc-L-[2,3-3H]GluGlu-Val with solvent could be detected during the carboxylation. If the same situation holds for the fluorinated peptide, this makes the formation of the 2,3-dehydropeptide by abstraction of the 2-hydrogen very unlikely.)
Provided that the presence of fluorine does not induce a driving force sufficient to modify the reaction pathway when going from Boc-Glu-Glu-Val to Boc-Glu(3F)-Glu- and H-4 are not fulfilled by the threo isomer whereas the proper conformation is achieved with the erythro isomer. We have already observed such a reactivity difference between the threo-and erythro-3-fluoroglutamate isomers during reaction with glutamate decarboxylase (VidalCros et al., 1985b) : the threo isomer simply decarboxylates whereas the erythro isomer decarboxylates and eliminates an F-anion.
CONCLUSION
The erythro-Boc-Glu(3F)-Glu-Val yielded an HFelimination product upon carboxylation. The most attractive mechanism that can rationalize this result is an F-elimination on a carbanion intermediate (Scheme 1, pathway b).
However, the present study does not rule out a radicalmediated mechanism yielding first a radical species that would be reduced into a carbanion in a second step (Scheme 1, pathway c). This pathway has to be tested.
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